Vimarsana
Biggest News Aggregation in the World

Page 23 - Wdif News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Wdif. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Wdif Today - Breaking & Trending Today

COVID-19: Panacea Biotec, RDIF to start Sputnik V production in India - Vimarsana News

COVID-19: Panacea Biotec, RDIF to start Sputnik V production in India

COVID-19: Panacea Biotec, RDIF to start Sputnik V production in India RDIF and Panacea have agreed to produce 100 million doses per year of Sputnik V. File photo Updated: May 24, 2021, 05:46 PM IST Panacea Biotec, one of India's largest pharmaceutical companies and the Russian Direct Investment Fund (RDIF) of Russia have taken a major decision to increase the production of coronavirus vaccine in the country. The two companies have announced that they will produce 100 million doses of 100 million Russian Sputnik V every year. In a statement, Panacea Biotec Ltd (PB...

Prices of Sputnik V COVID-19 vaccine may drop after local manufacturing begins: Dr Reddy's - Vimarsana News

Prices of Sputnik V COVID-19 vaccine may drop after local manufacturing begins: Dr Reddy's

Prices of Sputnik V COVID-19 vaccine may drop after local manufacturing begins: Dr Reddy's ANI | Updated: May 20, 2021 19:22 IST Hyderabad (Telangana) [India], May 20 (ANI): The pricing of the Sputnik VCOVID-19 vaccine, currently capped at Rs 995 per dose, is expected to come down once local manufacturing of the vaccine begins, according to a company spokesperson from Dr Reddy's Laboratories. The company spokesperson told ANI: "The current MRP of Rs. 948 + 5 per cent GST is for the imported doses. We are not able to provide a specific number but as indica...

Source: aninews.in
Sputnik V: Second batch of vaccines to arrive from Russia - The Hindu BusinessLine - Vimarsana News

Sputnik V: Second batch of vaccines to arrive from Russia - The Hindu BusinessLine

Sputnik V to be available in market from next week: VK Paul May 13, 2021 Second batch of 3 lakh doses to arrive on Friday Sputnik V, developed by Gamaleya Research Institute of Epidemiology and Microbiology, will be available in the market from next week, VK Paul, Member-Health, NITI Aayog, said on Thursday. Sputnik V is the third vaccine to be approved for emergency use in India and is now registered in about 63 countries. Meanwhile, the second batch of the vaccine is expected to land in India on Friday. Dr Reddy’s Laboratories Ltd, a partner of Russia’s sovereign wealth fund Russian Dir...

Bangladesh's Orion Pharma contacts Russia to produce COVID vaccine - Vimarsana News

Bangladesh's Orion Pharma contacts Russia to produce COVID vaccine

  Staff Correspondent,  bdnews24.com Published: 05 May 2021 07:49 PM BdST Updated: 05 May 2021 07:49 PM BdST Bangladeshi drugmaker Orion Pharma Ltd has reached out to Russia to manufacture the coronavirus vaccine in the country. "); } The company disclosed the development on the Dhaka Stock Exchange on Wednesday, saying it has approached the Russian Direct Investment Fund or RDIF to transfer the technology to produce the vaccine at Orion’s plant. RDIF is a government agency that looks after foreign investments made in Russian companies. Orion Pharma said it communicated with the Directo...

RDIF: Turkey becomes 63rd country in the world to authorize Sputnik V - Vimarsana News

RDIF: Turkey becomes 63rd country in the world to authorize Sputnik V

The vaccine has been registered in Turkey under the emergency use authorization procedure (EUA).